DBS Sticks to Their Hold Rating for Raffles Medical Group (RAFLF)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 24 2025
0mins
Source: Business Insider
Analyst Rating: DBS analyst Rachel Tan has maintained a Hold rating on Raffles Medical Group with a price target of S$0.97, while the stock closed at $0.60 last Thursday. The overall analyst consensus for the company is also a Hold, with a price target of $0.73.
Insider Activity: There is positive sentiment among corporate insiders regarding RAFLF, as evidenced by an increase in insider purchases over the past quarter, despite Tan's average return being -9.2% with a 39.13% success rate.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
